申万菱信医药先锋股票C(015171)利润分配表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
收入 |
-170,728,453.53 |
-179,589,093.36 |
-174,685,529.51 |
-63,621,880.52 |
利息合计 |
163,078.77 |
127,926.70 |
374,212.04 |
168,489.48 |
其中:存款利息收入 |
163,078.77 |
127,926.70 |
374,212.04 |
168,489.48 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
- |
投资收益合计 |
-248,976,642.01 |
-194,394,080.98 |
-59,563,497.41 |
-15,116,708.31 |
其中:股票投资收益 |
-249,859,944.43 |
-194,505,096.55 |
-64,669,001.63 |
-19,532,700.05 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
-405,784.24 |
-425,787.47 |
46,667.80 |
46,667.80 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
1,289,086.66 |
536,803.04 |
5,058,836.42 |
4,369,323.94 |
基金分红收益收益 |
- |
- |
- |
- |
公允价值变动收益 |
77,762,340.10 |
14,517,429.02 |
-116,302,038.20 |
-49,347,854.02 |
其他收入 |
322,769.61 |
159,631.90 |
805,794.06 |
674,192.33 |
费用 |
5,707,330.31 |
4,378,815.28 |
14,781,527.40 |
6,737,875.87 |
管理人报酬 |
4,135,045.00 |
3,127,990.47 |
10,841,315.56 |
5,028,810.19 |
基金托管费 |
689,174.09 |
521,331.70 |
1,806,885.90 |
838,135.07 |
销售服务费 |
671,320.23 |
622,061.51 |
1,915,494.16 |
758,247.66 |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
211,787.63 |
107,428.24 |
217,831.78 |
112,682.95 |
利润总额 |
-176,435,783.84 |
-183,967,908.64 |
-189,467,056.91 |
-70,359,756.39 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年